ArticleCureus2025
Recurrent Guillain-Barré Syndrome Following Ischemic Stroke: A Rare Case With a Four-Year Inter-Episode Interval.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Guillain-Barré syndrome (GBS) is an acute immune-mediated polyradiculoneuropathy that typically follows infections and is usually monophasic, with recurrence occurring in only a few cases. Its development after cerebrovascular events is exceedingly rare, complicating timely recognition due to overlapping neurological deficits. We describe a 67-year-old man who, four years earlier, experienced an acute right basal ganglia ischemic stroke and, on the fourth day of hospitalization, developed rapidly progressive quadriparesis and areflexia. Initial suspicion for stroke recurrence or hemorrhagic transformation was excluded by neuroimaging. Cerebrospinal fluid analysis revealed albuminocytologic dissociation, and nerve conduction studies demonstrated acute motor-sensory axonal neuropathy (AMSAN), confirming GBS. He was treated with intravenous immunoglobulin, achieving a gradual recovery. Four years later, he presented with spontaneous ascending weakness and respiratory compromise. Cerebrospinal fluid protein was elevated, and repeat nerve conduction studies showed acute inflammatory demyelinating polyneuropathy (AIDP). Plasmapheresis, supportive care, and structured rehabilitation resulted in substantial neurological improvement. This case highlights the rare occurrence of GBS following stroke and the potential for recurrence years later, even without identifiable triggers. It underscores the need for high clinical suspicion in post-stroke patients with new neuromuscular deficits, the utility of serial electrophysiological evaluation for subtype classification, and the importance of timely immunotherapy and vigilant supportive care. Recognition of such atypical presentations is essential to reduce morbidity, prevent respiratory failure, and guide long-term follow-up for recurrent episodes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.